Surrogate biomarkers identification for neuropsychiatric lupus by proteomic fingerprint technology
10.3760/cma.j.issn.1007-7480.2012.06.010
- VernacularTitle:蛋白指纹图谱技术筛选神经精神狼疮的生物标志物
- Author:
Huan CHEN
;
Ling SUN
;
Hua CHEN
;
Chaojun HU
;
Yongzhe LI
;
Peng WANG
;
Jing XIE
;
Denian BA
;
Wei HE
;
Xuan ZHANG
- Publication Type:Journal Article
- Keywords:
Lupus vasculitis,central nervous system;
Biological markers;
Proteomic fingerprint
- From:
Chinese Journal of Rheumatology
2012;16(6):402-405
- CountryChina
- Language:Chinese
-
Abstract:
Objective To identify biomarkers in cerebrospinal fluid (CSF) by proteomic technology and develop a diagnostic model for neuropsychiatric lupus (NPSLE).Methods CSF proteomic spectra of 27 patients with NPSLE before and after treatment,and 27 controls including 17 patients with scoliosis,and 10 SLE patients without neuropsychiatric manifestation (non-NPSLE) were generated by matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF-MS) combined with weak cationic exchange (WCX) magnetic beads.Data were analyzed with t test,non-parametric Kruskal-Wallis H test or Wilcoxon sign-rank test.A decision tree model for NPSLE classification was built based on the discriminating peaks.In addition,CSF samples of 12 patients with NPSLE,12 patients with lumbar disc herniation and 9 patients with other neurological conditions were employed as blind test group to verify the accuracy of the model.Results Twelve discriminating mass-to-charge (m/z) peaks were identified between NPSLE and controls.The diagnostic decision tree model,built with a panel of m/z peaks 8595,7170,7661,7740 and 5806,recognized NPSLE with the sensitivity and specificity of 92.6％ and 92.6％ based on training group samples,91.7％ and 85.7％ based on blind test group,respectively.Conclusion Potential CSF NPSLE biomarkers are identified by proteomic technology,the novel diagnostic model is sensitive and relatively specific for the diagnosis of NPSLE.
